Iconovo’s new collaboration aims to optimise current inhalation products

British CrystecPharma begins a collaboration with the Swedish inhaler developer Iconovo with the aim of formulating new innovative compounds for use in dry powder inhalers.

The two companies’ technologies complement each other, and the purpose of the collaboration is to produce a complete solution for customers needing optimal delivery of effective molecules to or via the lungs. A pilot project has already been launched. Read more